AstraZeneca boosts open innovation efforts


Astrazeneca (AZ) has launched a new web portal, bringing together new and existing open innovation programmes. The aim is to make collaboration with academics, other companies, governments and non-government organisations easier.

Like a growing number of pharmaceutical companies, AZ already collaborates extensively with academics and other organisation. However, it wants to open up these programmes and encourage potential collaborators. AZ will offer access to its compound library, tool compounds for biological investigations, screening for target validation and various other services. There will also be rewards for researchers who suggest solutions for challenges the company is facing.

‘To push the boundaries of science and deliver new medicines to patients, we need to create a more permeable research environment,’ said AZ’s Mene Pangalos in a statement. ‘An essential part of that is making our knowledge and compounds more accessible.’

This move follows several similar initiatives from other companies: most notably GlaxoSmithKline, which has opened up extensive chunks of its compound libraries and runs collaborative drug discovery contests; Eli Lilly, which has ongoing target-based and phenotypic screening services available to potential collaborators; and a consortium of Japanese firms.


Related Content

The hunt for innovation

31 January 2014 Premium contentFeature

news image

Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom

Data-sharing partnership for drug discovery

28 June 2013 Business

news image

Collaborative project aims to assist medicinal chemistry efforts

Most Read

UC Davis chemist sentenced to four years over explosion

19 November 2014 News and Analysis

news image

Postdoc sentenced over attempt to make explosive device and reckless disposal of hazardous waste

Spanish fly

10 October 2013 Podcast | Compounds

news image

Helen Scales looks at cantharidin, the active ingredient in this famous aphrodisiac

Most Commented

Beetle behind breath test for bank notes

17 November 2014 Research

news image

Photonic crystal inks inspired by longhorn beetle could help to fight counterfeiting

Bayer wins race to buy Merck & Co consumer care

9 May 2014 Business

news image

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company